Pregled bibliografske jedinice broj: 698666
The value of 99mTc EDDA/HYNIC-TOC SPECT/CT in assessment of patients with metastatic neuroendocrine tumours of unknown primary or suspicion of NET, Initial Experience
The value of 99mTc EDDA/HYNIC-TOC SPECT/CT in assessment of patients with metastatic neuroendocrine tumours of unknown primary or suspicion of NET, Initial Experience // Annual Congress of the European Association of Nuclear Medicine
Lion-sur-Mer, Francuska, 2013. (poster, međunarodna recenzija, sažetak, ostalo)
CROSBI ID: 698666 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The value of 99mTc EDDA/HYNIC-TOC SPECT/CT in assessment of patients with metastatic neuroendocrine tumours of unknown primary or suspicion of NET, Initial Experience
Autori
Trogrlić, Mate ; Težak, Stanko ; Žuvić, Marijan
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, ostalo
Skup
Annual Congress of the European Association of Nuclear Medicine
Mjesto i datum
Lion-sur-Mer, Francuska, 19.10.2013. - 23.10.2013
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
99mTc EDDA/HYNIC-Tyr3-octreotide; SPECT/CT; metastatic NET
Sažetak
99mTc EDDA/HYNIC-TOC SPECT/CT is useful functional imaging modality in evaluation of patients with suspicion of NETs. Excellent sensitivity in group 1 was probably due to relatively short (one year) follow-up period. Even if 99mTc EDDA/HYNIC-TOC SPECT/CT doesn´t give exact localization of primary tumor it may provide an accurate staging of metastatic NETs.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
